BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11249731)

  • 1. Monitoring cellular immune responses to cancer immunotherapy.
    Morse MA; Clay TM; Hobeika AC; Mosca PJ; Lyerly HK
    Curr Opin Mol Ther; 2001 Feb; 3(1):45-52. PubMed ID: 11249731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for monitoring cellular immune responses to active immunotherapy of cancer.
    Clay TM; Hobeika AC; Mosca PJ; Lyerly HK; Morse MA
    Clin Cancer Res; 2001 May; 7(5):1127-35. PubMed ID: 11350875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitating therapeutically relevant T-cell responses to cancer vaccines.
    Hobeika AC; Clay TM; Mosca PJ; Lyerly HK; Morse MA
    Crit Rev Immunol; 2001; 21(1-3):287-97. PubMed ID: 11642610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
    Schultze JL; Grabbe S; von Bergwelt-Baildon MS
    Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.
    Yee C; Greenberg P
    Nat Rev Cancer; 2002 Jun; 2(6):409-19. PubMed ID: 12189383
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct detection of cellular immune responses to cancer vaccines.
    Mosca PJ; Hobeika AC; Clay TM; Morse MA; Lyerly HK
    Surgery; 2001 Mar; 129(3):248-54. PubMed ID: 11231452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral oncolysates in cancer treatment: immunological mechanisms of action (review).
    Ioannides CG; Platsoucas CD; O'Brian CA; Patenia R; Bowen JM; Wharton JT; Freedman RS
    Anticancer Res; 1989; 9(3):535-44. PubMed ID: 2669619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG in cancer and leukemia treatment and prophylaxis-A review.
    Rosenthal SR
    J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of antitumor immune responses by hematopoietic cytokines.
    Waller EK; Ernstoff MS
    Cancer; 2003 Apr; 97(7):1797-809. PubMed ID: 12655538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supernatural T cells: genetic modification of T cells for cancer therapy.
    Kershaw MH; Teng MW; Smyth MJ; Darcy PK
    Nat Rev Immunol; 2005 Dec; 5(12):928-40. PubMed ID: 16322746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.